Bill > SB1279

This bill modifies the requirements for collaborative practice arrangements between physicians and registered professional nurses. Key provisions include: - Allowing advanced practice registered nurses (APRNs) to administer, dispense, or prescribe certain controlled substances, including Schedule III-V and Schedule II hydrocodone, with limitations. APRNs can also prescribe buprenorphine for up to 30 days for medication-assisted treatment. - Specifying the required contents of the written collaborative practice agreement, such as geographic proximity requirements (which can be waived in certain circumstances), controlled substance prescriptive authority, and chart review procedures. - Allowing the state boards of registration for the healing arts and nursing to jointly promulgate rules regulating collaborative practice arrangements, with some limitations. - Placing a cap of six full-time equivalent APRNs, physician assistants, or assistant physicians per collaborating physician, with exceptions. - Requiring the collaborating physician to review a minimum percentage of the APRN's patient charts every 14 or 30 days, depending on whether controlled substances are prescribed.